SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-091417
Filing Date
2020-08-06
Accepted
2020-08-06 16:05:11
Documents
3
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026819-2_8k.htm 8-K 19662
2 EXHIBIT 99.1 tm2026819d2_ex99-1.htm EX-99.1 107811
3 GRAPHIC tm2026819d2_ex99-1img001.jpg GRAPHIC 5635
  Complete submission text file 0001104659-20-091417.txt   136535
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 201081536
SIC: 2834 Pharmaceutical Preparations